Next-Generation Proteasome Inhibition in Multiple Myeloma

PharmD, BCPS

Founding Editor in Chief

Supported by funding from Onyx Pharmaceuticals, Inc.

*This publication is not sponsored by, endorsed by, or affiliated with the American Society of Hematology in any way.

Articles

We Value Your Feedback! Tell Us How You Consume Content